Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease

REFERENCES

• Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, et al. Atriopeptins as cardiac hormones. Hypertension 1985; 7: 469 — 82.
   PubMed Web of Science ®Google Scholar
• Cantin M, Genest J. The heart and the atrial natriuretic factor. Endocr Rev 1985; 6: 107 — 27.
   PubMed Web of Science ®Google Scholar
• Thibault G, Garcia R, Gutkowska J, Bilodeau J, Lazure C, Seidah NG, et al. The propeptide Asn 1 — Tyr 126 is the storage form of rat atrial natriuretic factor. Biochem J 1987; 241: 265–72.
   PubMed Web of Science ®Google Scholar
• Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, et al. Atrial natriuretic polypeptide (7ANP) -derived peptides in human plasma: cosecretion of N-terminal yANP fragment and ccANP. J Clin Endocrinol Metabol 1988; 67: 429 — 37.
   PubMed Web of Science ®Google Scholar
• DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to the intravenous injection of atrial myo-cardial extract in rats. Life Sci 1981; 28: 89–94.
   PubMed Web of Science ®Google Scholar
• Vesely DL, Norris JS, Walters JM, Jespersen RR, Baeyens DA. Atrial natriuretic prohormone peptides 79–98, 31 — 67 and 79–98 vasodilate the aorta. Biochem Biophys Res Commun 1987; 148: 1540 — 8.
   Google Scholar
• Pevahouse JB, Martin DR, Trigg DJ, Winters CJ, Vesely DL, Buerkert JE. Prohormone atrial natriuretic peptide 31 — 67 as well as atrial natriuretic factor causes a marked natriuresis. Clin Res 1989; 37: 583.
   Google Scholar
• Martin DR, Pevahouse JB, Trigg DJ, Vesely DL, Buerkert JE. Three peptides from the ANF pro- hormone NH2-terminus are natriuretic and/or kaliuretic. Am J Physiol 1990; 258: F1401 —8.
   Google Scholar
• Vesely DL, Douglass MA, Dietz JR, Gower WR, McCormick MT, Rodriguez-Paz G, et al. Three peptides from the atrial natriuretic factor prohor-mone amino terminus lower blood pressure and produce diuresis, natriuresis and/or kaliuresis in humans. Circulation 1994; 90: 1129–40.
   Google Scholar
• Vesely DL, Chiou S, Douglass MA, McCormick MT, Rodriguez-Paz G, Schocken DD. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic peptide inhibit aldosterone secretion. J Endocrinology 1995; 146: 373 — 80.
   Google Scholar
• Vesely DL, Sallman AL, Bayliss JM. Specific bind-ing sites for pro atrial natriuretic factors 1 —30, 31 — 67 and 99 — 126 on distal nephrons, renal cor-tical and medullary membranes. Renal Physiol Biochem 1992; 15: 23 — 32.
   Google Scholar
• Vesely DL, Bayliss JM, Sallman AL. Human pre-proatrial natriuretic factors 26 — 55, 56-92 and 104 — 123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun 1987; 143: 186–93.
   Google Scholar
• Vesely DL, Douglass MA, Dietz JR, Giordano AT, McCormick MT, Rodriguez-Paz G, et al. Negative feedback of atrial natriuretic peptides. J Clin Endocrin Metabol 1994; 78: 1128— 34.
   PubMed Web of Science ®Google Scholar
• Itoh H, Nakao K, Mukoyama M, Sugawara A, Saito Y, Morii N, et al. Secretion of N-terminal fragment of a-human atrial natriuretic poly-peptide. Hypertension 1988; 11 Suppl I: 152 — 56.
   Google Scholar
• Meleagros L, Ghatei MA, Gibbs JSR, Bloom SR. Pro-atrial natriuretic peptide (1-98): the circu-lating cardiodilatin in man. Peptides 1989; 10: 545 — 50.
   PubMed Web of Science ®Google Scholar
• Buckley MG, Sagnella GA, Markandu ND, Singer DRJ, MacGregor GA. Concentrations of N-term-inal ProANP in human plasma: evidence for ProANP (1–98) as the circulating form. Clin Chim Acta 1990; 191: 1 — 14.
   Google Scholar
• Vesely DL, Norsk P, Winters CJ, Rico DM, Sallman AL, Epstein M. Increased release of the N-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced cen-tral hypervolemia in normal humans. Proc Soc Exp Biol Med 1989; 192: 230 — 5.
   PubMed Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL. The N-terminus and a 4000 molecular weight peptide from the mid portion of the N-terminus of the atrial natriuretic factor pro-hormone each circulate in man and increase in congestive heart failure. Circulation 1989; 80: 438 —49.
   PubMed Web of Science ®Google Scholar
• Gower WR, Chiou S, Skolnick KA, Vesely DL. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994; 15: 861 — 7.
   PubMed Web of Science ®Google Scholar
• Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain and C-natriuretic prohormone peptides compared as early failure indicators. Cardiovascular Research 1997; 36: 246–55.
   PubMed Web of Science ®Google Scholar
• Prowse C, George E, Micklem LR, Hornsey V, Brown J, James K. Human atrial natriuretic factor (ANF): characterisation of a monoclonal antibody panel and its use in radioimmunoassay. J Immunol Meth 1989; 118: 91 — 100.
   PubMed Web of Science ®Google Scholar
• Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ. Iodination of proteins, glyco-proteins and peptides using a solid phase oxidising agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycouril (Iodogen). Analyt Biochem 1981; 117: 136–46.
   Google Scholar
• Bailey NTJ. Statistical methods in biology. 3rd edn. Cambridge: Cambridge University Press, 1995: 216.
   Google Scholar
• Hartter E, Weissel M, Stummvoll HK, Woloszczuk W, Punzengruber C, Ludvik B. Atrial natriuretic peptide concentrations in blood from right atrium in patients with severe right heart failure. Lancet 1985; 2: 93–4.
   PubMed Web of Science ®Google Scholar
• Fyhrquist F, Tikkanen I. Atrial natriuretic peptide in congestive heart failure. Am J Cardiol 1988; 62: A20–4.
   PubMed Web of Science ®Google Scholar
• Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentration of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metabol 1988; 66: 605 — 10.
   PubMed Web of Science ®Google Scholar
• Meleagros L, Gibbs JSR, Ghatei MA, Bloom SR. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Br Heart J 1988; 60: 39–44.
   PubMedGoogle Scholar
• Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohor-mone each circulate in humans and increase in congestive heart failure. Circulation 1989; 80: 438 —49.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Decreased density for binding sites of atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci 1988; 74: 213–8.
   Web of Science ®Google Scholar
• Omland T, Bonarjee VVS, Nilsen DWT, Sundsfjord JA, Lie RT, Thibault G, etal. Prognos-tic significance of N-terminal pro-atrial natriuretic factor (1 —98) in acute myocardial infarction: com-parison with atrial natriuretic factor (99— 126) and clinical evaluation. Br Heart J 1993; 70: 409— 14.
   Google Scholar
• Hall C, Rouleau JL, Moye L, de Champlain J, Bichet D, Klein M, et al. N-terminal proatrial natriuretic factor. Circulation 1994; 89: 1934 — 42.
   PubMed Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Meadows J, Rico DM, Vesely DL. Two new hormones: prohormone atrial natriuretic peptides 1–30 and 31 — 67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231 — 6.
   Google Scholar
• Katsube N, Schwartz D, Needleman P. Atrio-peptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J Pharmacol Exp Ther 1986; 239: 474 — 9.
   Google Scholar
• Arendt RM, Stagl E, Zahringer J, Liebisch DC, Herz A. Demonstration and characterization of a-human atrial natriuretic factor in human plasma. FEBS Lett 1985; 189: 57 — 61.
   Google Scholar
• Miyata A, Toshimoro T, Hashiguchi T, Kangawa K, Matsuo H. Molecular forms of atrial natriuretic polypeptides circulating in human plasma. Bio-chem Biophys Res Commun 1985; 142: 461 — 7.
   Google Scholar
• Ando K, Hirata Y, Emori T, Shichiri M, Kurosawa T, Sato K, etal. Circulating forms of human atrial natriuretic peptide in patients with congestive heart failure. J Clin Endocrinol Metabol 1990; 70: 1603— 7.
   Google Scholar
• Chang ACY, Cochet M, Cohen SN. Structural organisation of human genomic DNA encoding the proopiomelanocortin peptide. Proc Natl Acad Sci USA 1980; 77: 4890–4.
   PubMed Web of Science ®Google Scholar
• Jackson S, Spruce A, Glover DM, Glynn BP, Lowry PJ. Identification of high molecular weight peptides in bovine adrenomedullary chromaffin granules using monoclonal antibodies to a Proen-kephalin A fusion peptide. J Mol Endocrinol 1989; 2: 119 — 29.
   Google Scholar
• Anderson JV, Donckier J, Payne NN, Beacham J, Slater JDH, Bloom SR. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at phy-siological plasma concentrations in man. Clin Sci 1987; 72: 305–12.
   PubMed Web of Science ®Google Scholar
• Solomon LR, Atherton JC, Bobinski H, Green R. Effect of posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clin Sci 1986; 71: 299–305.
   PubMed Web of Science ®Google Scholar